Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Anti-TREK-1 Autoantibodies as Diagnostic and Prognostic Biomarkers in Short-Coupled Ventricular Fibrillation

NCT06943365 is registered in ClinicalTrials.gov with Institut universitaire de cardiologie et de pneumologie de Québec, University Laval as lead sponsor.

NCT NCT06943365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06943365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Anti-TREK-1 Autoantibodies as Diagnostic and Prognostic Biomarkers in Short-Coupled Ventricular Fibrillation
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic ventricular fibrillation, short-coupled ventricular fibrillation